ArticleOncology letters2026
FUBP3 regulates expression and alternative splicing of genes associated with cell proliferation and apoptosis in cancer cells.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Far upstream element binding protein (FUBP)3, a member of the FUBP family of proteins, is a DNA-binding transcription activator and an RNA-binding protein. FUBP3 is deregulated in various types of human cancer and promotes cell proliferation. However, the underlying molecular mechanism of FUBP3 in cancer is still unclear. Therefore, the present study investigated the cell biology, gene expression profile and alternative splicing pattern of HeLa and Huh7 cells following FUBP3 knockdown, in comparison with control cells. The results showed that FUBP3 knockdown promoted proliferation and inhibited apoptosis of HeLa cells, but inhibited the proliferation of Huh7 cells. FUBP3 knockdown markedly affected the transcriptional level of genes involved in cell adhesion, cell proliferation and the apoptotic process. Furthermore, FUBP3 broadly regulated the alternative splicing of hundreds of genes with functions in cellular component disassembly and the apoptotic process. Validation experiments using reverse transcription-quantitative PCR demonstrated that FUBP3 regulated the expression and alternative splicing of genes associated with cell adhesion, cell proliferation and apoptosis in the HeLa and Huh7 cells lines. These results indicated that FUBP3 could regulate the proliferation and apoptosis of cancer cells perhaps via different gene expression and splicing regulation, which thus furthers the current understanding of the role of FUBP3 in cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.